Literature DB >> 2242313

Urinary oxalate and glycolate excretion in healthy infants and children.

E P Leumann1, A Dietl, A Matasovic.   

Abstract

The molar ratios of oxalate and glycolate over creatinine were determined in single urine samples of 26 infants and 27 children aged 1-5 years. In 135 children aged 5-16 years, two urine specimens were collected, one before breakfast and one at noon. Oxalate was determined by oxalate oxidase, and glycolate was measured by a colorimetric method (improved chromatotropic acid--sulphuric acid assay after prior purification by cation and anion exchanger). Both ratios (expressed in mmol/mol creatinine and analysed on a log-normal basis) were highest in infants 0-6 months old [mean oxalate 147 (95% confidence interval: 60-360), mean glycolate 175 (72-425)]. The mean oxalate ratio was 72 mmol/mol (29-174) at the age of 7-24 months, 44 (19-101) at the age of 2-5 years and 22 (12-40) in adolescents aged 16 years. Molar glycolate ratios were higher, but disclosed the same pattern. Oxalate and glycolate ratios in fasting urines did not differ significantly from those in noon samples (except glycolate in the oldest age group). Oxalate ratios correlated well with glycolate ratios in children up to 5 years of age only. Random urine samples are thus suitable for screening. However, interpretation of data requires use of age-specific reference values that are based on comparable methods.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242313     DOI: 10.1007/bf00869828

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  The variation of urinary oxalate excretion with age.

Authors:  D A Gibbs; R W Watts
Journal:  J Lab Clin Med       Date:  1969-06

2.  Urine uric acid to creatinine rtio--a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout.

Authors:  J M Kaufman; M L Greene; J E Seegmiller
Journal:  J Pediatr       Date:  1968-10       Impact factor: 4.406

3.  Removal of ascorbate from urine prior to assaying with a commercial oxalate kit.

Authors:  G P Kasidas; G A Rose
Journal:  Clin Chim Acta       Date:  1987-04-30       Impact factor: 3.786

4.  The effects of pH, temperature and storage on urine oxalate.

Authors:  E A Braiotta; J E Buttery; N Ludvigsen
Journal:  Clin Chim Acta       Date:  1985-03-30       Impact factor: 3.786

5.  Urinary oxalate estimation.

Authors:  F M Olthuis; A M Markslag; J T Klein Elhorst; P G Krugers Dagneaux
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

6.  Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition.

Authors:  T Campfield; G Braden
Journal:  Pediatrics       Date:  1989-11       Impact factor: 7.124

7.  New aspects of infantile oxalosis.

Authors:  E P Leumann; A Niederwieser; A Fanconi
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

8.  Oxalosis in infancy.

Authors:  M C Morris; T L Chambers; P W Evans; P N Malleson; J R Pincott; G A Rose
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

9.  Glycolic acid in urine. A colorimetric method with values in normal adult controls and in patients with primary hyperoxaluria.

Authors:  A Niederwieser; A Matasović; E P Leumann
Journal:  Clin Chim Acta       Date:  1978-10-02       Impact factor: 3.786

10.  The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?

Authors:  W G Robertson; M Peacock
Journal:  Nephron       Date:  1980       Impact factor: 2.847

  10 in total
  14 in total

1.  Nephrocalcinosis in preterm babies.

Authors:  A Narendra; M P White; H A Rolton; Z I Alloub; G Wilkinson; J H McColl; J Beattie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

2.  Urinary oxalate excretion in urolithiasis and nephrocalcinosis.

Authors:  T J Neuhaus; T Belzer; N Blau; B Hoppe; H Sidhu; E Leumann
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

Review 3.  Management of primary hyperoxaluria: efficacy of oral citrate administration.

Authors:  E Leumann; B Hoppe; T Neuhaus
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 4.  An update on primary hyperoxaluria.

Authors:  Bernd Hoppe
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

5.  Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.

Authors:  Neveen A Soliman; Marwa M Nabhan; Safaa M Abdelrahman; Hanan Abdelaziz; Rasha Helmy; Khaled Ghanim; Hafez M Bazaraa; Ahmed M Badr; Omar A Tolba; Magd A Kotb; Khaled M Eweeda; Alaa Fayez
Journal:  Nephrol Ther       Date:  2017-02-01       Impact factor: 0.722

6.  Urolithiasis in the first year of life.

Authors:  Ayfer Gür Güven; Mustafa Koyun; Yunus Emre Baysal; Sema Akman; Emel Alimoglu; Halide Akbas; Adnan Kabaalioglu
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

7.  Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis.

Authors:  Concepción Sáez-Torres; Félix Grases; Dolores Rodrigo; Ana María García-Raja; Cristina Gómez; Guillem Frontera
Journal:  Pediatr Nephrol       Date:  2012-12-02       Impact factor: 3.714

Review 8.  The primary hyperoxalurias.

Authors:  Bernd Hoppe; Bodo B Beck; Dawn S Milliner
Journal:  Kidney Int       Date:  2009-02-18       Impact factor: 10.612

9.  Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol.

Authors:  Concepción Sáez-Torres; Dolores Rodrigo; Félix Grases; Ana M García-Raja; Cristina Gómez; Javier Lumbreras; Guiem Frontera
Journal:  Pediatr Nephrol       Date:  2014-02-12       Impact factor: 3.714

Review 10.  Diagnostic examination of the child with urolithiasis or nephrocalcinosis.

Authors:  Bernd Hoppe; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-12-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.